{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:14:48Z","timestamp":1793823288332,"version":"4.6.1"},"reference-count":169,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Nephrotic syndrome (NS) is a clinical entity characterized by proteinuria, hypoalbuminemia, and peripheral edema. NS affects about 2\u20137 per 100,000 children aged below 18 years old yearly and is classified, based on the response to drugs, into steroid sensitive (SSNS), steroid dependent, (SDNS), multidrug dependent (MDNS), and multidrug resistant (MRNS). Forms of NS that are more difficult to treat are associated with a worse outcome with respect to renal function. In particular, MRNS commonly progresses to end stage renal failure requiring renal transplantation, with recurrence of the original disease in half of the cases. Histological presentations of NS may vary from minimal glomerular lesions (MCD) to focal segmental glomerulosclerosis (FSGS) and, of relevance, the histological patterns do not correlate with the response to treatments. Moreover, around half of MRNS cases are secondary to causative pathogenic variants in genes involved in maintaining the glomerular structure. The pathogenesis of NS is still poorly understood and therapeutic approaches are mostly based on clinical experience. Understanding of pathogenetic mechanisms of NS is one of the \u2018unmet needs\u2019 in nephrology and represents a significant challenge for the scientific community. The scope of the present review includes exploring relevant findings, identifying unmet needs, and reviewing therapeutic developments that characterize NS in the last decades. The main aim is to provide a basis for new perspectives and mechanistic studies in NS.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1167741","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T20:00:31Z","timestamp":1689192031000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["State of the art in childhood nephrotic syndrome: concrete discoveries and unmet needs"],"prefix":"10.3389","volume":"14","author":[{"given":"Flavio","family":"Vincenti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Marco","family":"Ghiggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14184-0","article-title":"Nephrotic syndrome in childhood","volume":"362","author":"Eddy","year":"2003","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2215\/CJN.06260614","article-title":"Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort","volume":"10","author":"Trautmann","year":"2015","journal-title":"Clin J Am Soc Nephrol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1053\/snep.2003.50012","article-title":"Pathologic classification of focal segmental glomerulosclerosis","volume":"23","author":"D'Agati","year":"2003","journal-title":"Semin Nephrol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2016.147","article-title":"Minimal change disease and idiopathic FSGS: manifestations of the same disease","volume":"12","author":"Maas","year":"2016","journal-title":"Nat Rev Nephrol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0217-5","article-title":"Molecular stratification of idiopathic nephrotic syndrome","volume":"15","author":"Saleem","year":"2019","journal-title":"Nat Rev Nephrol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0140-6736(82)92718-0","article-title":"Nephrotic syndrome induced by insect sting","volume":"2","author":"Tareyeva","year":"1982","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.06400420","article-title":"COVID-19 in children with nephrotic syndrome on anti-CD20 chronic immunosuppression","volume":"15","author":"Angeletti","year":"2020","journal-title":"Clin J Am Soc Nephrol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrneph.2017.167","article-title":"Genomic medicine for kidney disease","volume":"14","author":"Groopman","year":"2018","journal-title":"Nat Rev Nephrol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.280","article-title":"The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines\u2013application to the individual patient","volume":"82","author":"Radhakrishnan","year":"2012","journal-title":"Kidney Int"},{"key":"B10","article-title":"Chapter 3: steroid-sensitive nephrotic syndrome in children","volume":"2","year":"2012","journal-title":"Kidney Int Suppl (2011)"},{"key":"B11","article-title":"Chapter 4: steroid-resistant nephrotic syndrome in children","volume":"2","year":"2012","journal-title":"Kidney Int Suppl (2011)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00467-022-05739-3","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome","volume":"38","author":"Trautmann","year":"2023","journal-title":"Pediatr Nephrol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014080799","article-title":"Rituximab in children with steroid-dependent nephrotic syndrome: a multicenter, open-label, noninferiority, randomized controlled trial","volume":"26","author":"Ravani","year":"2015","journal-title":"J Am Soc Nephrol."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60541-9","article-title":"Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"384","author":"Iijima","year":"2014","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.211","article-title":"Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome","volume":"84","author":"Ravani","year":"2013","journal-title":"Kidney Int"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2011080775","article-title":"Rituximab in children with resistant idiopathic nephrotic syndrome","volume":"23","author":"Magnasco","year":"2012","journal-title":"J Am Soc Nephrol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(18)30283-9","article-title":"Management of steroid-resistant nephrotic syndrome in children and adolescents","volume":"2","author":"Tullus","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.10.031","article-title":"Monogenic causes of chronic kidney disease in adults","volume":"95","author":"Connaughton","year":"2019","journal-title":"Kidney Int"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2012.12.019","article-title":"The rise of renal pathology in nephrology: structure illuminates function","volume":"61","author":"D'Agati","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2021060794","article-title":"Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology","volume":"33","author":"Watts","year":"2022","journal-title":"J Am Soc Nephrol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.04.017","article-title":"Pathogenic variants in the genes affected in alport syndrome (COL4A3-COL4A5) and their association with other kidney conditions: a review","volume":"78","author":"Savige","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2215\/CJN.04120417","article-title":"Whole exome sequencing of patients with steroid-resistant nephrotic syndrome","volume":"13","author":"Warejko","year":"2018","journal-title":"Clin J Am Soc Nephrol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2022.06.012","article-title":"Adult-onset focal segmental glomerulosclerosis with steroid-dependent nephrotic syndrome caused by a novel TBC1D8B variant: a case report and literature review","volume":"81","author":"Fang","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2021.01.008","article-title":"De novo TRIM8 variants impair its protein localization to nuclear bodies and cause developmental delay, epilepsy, and focal segmental glomerulosclerosis","volume":"108","author":"Weng","year":"2021","journal-title":"Am J Hum Genet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154423","article-title":"Multicentric carpotarsal osteolysis syndrome associated nephropathy: novel variants of MAFB gene and literature review","volume":"11","author":"Drovandi","year":"2022","journal-title":"J Clin Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/humu.24472","article-title":"Functional characterization of a novel TP53RK mutation identified in a family with Galloway-mowat syndrome","volume":"43","author":"Treimer","year":"2022","journal-title":"Hum Mutat"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1038\/s41467-018-04193-w","article-title":"Mutations in six nephrosis genes delineate a pathogenic pathway amenable to treatment","volume":"9","author":"Ashraf","year":"2018","journal-title":"Nat Commun"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017010027","article-title":"New insights into podocyte biology in glomerular health and disease","volume":"28","author":"Assady","year":"2017","journal-title":"J Am Soc Nephrol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V12122742","article-title":"Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis","volume":"12","author":"Caridi","year":"2001","journal-title":"J Am Soc Nephrol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000060578.79050.E0","article-title":"Broadening the spectrum of diseases related to podocin mutations","volume":"14","author":"Caridi","year":"2003","journal-title":"J Am Soc Nephrol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/73456","article-title":"Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis","volume":"24","author":"Kaplan","year":"2000","journal-title":"Nat Genet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1681\/ASN.2021111505","article-title":"Steroid-resistant nephrotic syndrome-associated &lt;i<MYO1E&lt;\/i< mutations have differential effects on myosin 1e localization, dynamics, and activity","volume":"33","author":"Liu","year":"2022","journal-title":"J Am Soc Nephrol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1109122","article-title":"INF2 mutations in charcot-Marie-Tooth disease with glomerulopathy","volume":"365","author":"Boyer","year":"2011","journal-title":"N Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/ng1592","article-title":"TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function","volume":"37","author":"Reiser","year":"2005","journal-title":"Nat Genet"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.391","article-title":"Expanding the spectrum of NPHS1-associated disease","volume":"76","author":"Pollak","year":"2009","journal-title":"Kidney Int"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.3390\/cells10102554","article-title":"Formins in human disease","volume":"10","author":"Labat-de-Hoz","year":"2021","journal-title":"Cells"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.04.029","article-title":"Oral coenzyme Q10 supplementation leads to better preservation of kidney function in steroid-resistant nephrotic syndrome due to primary coenzyme Q10 deficiency","volume":"102","author":"Drovandi","year":"2022","journal-title":"Kidney Int"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.02.022","article-title":"A multicenter retrospective study of calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene variants","volume":"103","author":"Malakasioti","year":"2023","journal-title":"Kidney Int"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017020171","article-title":"The use of sildenafil for glomerular disease","volume":"28","author":"Tardi","year":"2017","journal-title":"J Am Soc Nephrol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015080885","article-title":"Sildenafil prevents podocyte injury via PPAR-gamma-Mediated TRPC6 inhibition","volume":"28","author":"Sonneveld","year":"2017","journal-title":"J Am Soc Nephrol."},{"key":"B41","article-title":"The familial nephrotic syndrome. i. a European survey","volume":"1","author":"White","year":"1973","journal-title":"Clin Nephrol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017111185","article-title":"Transethnic, genome-wide analysis reveals immune-related risk alleles and phenotypic correlates in pediatric steroid-sensitive nephrotic syndrome","volume":"29","author":"Debiec","year":"2018","journal-title":"J Am Soc Nephrol."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017080859","article-title":"Strong association of the HLA-DR\/DQ locus with childhood steroid-sensitive nephrotic syndrome in the Japanese population","volume":"29","author":"Jia","year":"2018","journal-title":"J Am Soc Nephrol."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.05.029","article-title":"Common risk variants in NPHS1 and TNFSF15 are associated with childhood steroid-sensitive nephrotic syndrome","volume":"98","author":"Jia","year":"2020","journal-title":"Kidney Int"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310345","article-title":"APOL1 risk variants, race, and progression of chronic kidney disease","volume":"369","author":"Parsa","year":"2013","journal-title":"N Engl J Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00330121","article-title":"Prevalence of SARS-CoV-2-IgG antibodies in children with CKD or immunosuppression","volume":"16","author":"Morello","year":"2021","journal-title":"Clin J Am Soc Nephrol."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1508467","article-title":"Kidney diseases associated with human immunodeficiency virus infection","volume":"377","author":"Cohen","year":"2017","journal-title":"N Engl J Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.44","article-title":"The changing epidemiology of HIV-related chronic kidney disease in the era of antiretroviral therapy","volume":"86","author":"Mallipattu","year":"2014","journal-title":"Kidney Int"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00177","article-title":"Molecular mechanisms of injury in HIV-associated nephropathy","volume":"5","author":"Rednor","year":"2018","journal-title":"Front Med (Lausanne)."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-7191com","article-title":"The homophilic adhesion molecule sidekick-1 contributes to augmented podocyte aggregation in HIV-associated nephropathy","volume":"21","author":"Kaufman","year":"2007","journal-title":"FASEB J"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000128975.28958.C2","article-title":"Sidekick-1 is upregulated in glomeruli in HIV-associated nephropathy","volume":"15","author":"Kaufman","year":"2004","journal-title":"J Am Soc Nephrol."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1421953112","article-title":"Human trypanolytic factor APOL1 forms pH-gated cation-selective channels in planar lipid bilayers: relevance to trypanosome lysis","volume":"112","author":"Thomson","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(00)70055-2","article-title":"Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis","volume":"35","author":"Tanawattanacharoen","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V1261164","article-title":"Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate","volume":"12","author":"Markowitz","year":"2001","journal-title":"J Am Soc Nephrol."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2007.0118","article-title":"Lithium-induced nephrotic syndrome in a prepubertal boy","volume":"18","author":"Petersen","year":"2008","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00145.2016","article-title":"What we need to know about the effect of lithium on the kidney","volume":"311","author":"Gong","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99271","article-title":"mTOR-mediated podocyte hypertrophy regulates glomerular integrity in mice and humans","volume":"4","author":"Puelles","year":"2019","journal-title":"JCI Insight"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03751106","article-title":"High sirolimus levels may induce focal segmental glomerulosclerosis de novo","volume":"2","author":"Letavernier","year":"2007","journal-title":"Clin J Am Soc Nephrol."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2019.07.019","article-title":"Development of collapsing focal and segmental glomerulosclerosis after receiving intravitreal vascular endothelial growth factor blockade","volume":"4","author":"Nobakht","year":"2019","journal-title":"Kidney Int Rep"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2016.09.055","article-title":"Adverse renal effects of novel molecular oncologic targeted therapies: a narrative review","volume":"2","author":"Jhaveri","year":"2017","journal-title":"Kidney Int Rep"},{"key":"B61","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJMoa1215637","article-title":"Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia","volume":"369","author":"Byrd","year":"2013","journal-title":"N Engl J Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4287","article-title":"Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice","volume":"23","author":"Beckerman","year":"2017","journal-title":"Nat Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01850310","article-title":"Daily corticosteroids reduce infection-associated relapses in frequently relapsing nephrotic syndrome: a randomized controlled trial","volume":"6","author":"Gulati","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900574","article-title":"Ibrutinib and venetoclax for first-line treatment of CLL","volume":"380","author":"Jain","year":"2019","journal-title":"N Engl J Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-386417","article-title":"The bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo","volume":"119","author":"Ponader","year":"2012","journal-title":"Blood"},{"key":"B67","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/1615-9861(200202)2:2<197::AID-PROT197>3.0.CO;2-6","article-title":"Characterization of plasma factors that alter the permeability to albumin within isolated glomeruli","volume":"2","author":"Musante","year":"2002","journal-title":"Proteomics"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604043341402","article-title":"Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis","volume":"334","author":"Savin","year":"1996","journal-title":"N Engl J Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00968.x","article-title":"New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis","volume":"5","author":"Vincenti","year":"2005","journal-title":"Am J Transplant."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199111000-00014","article-title":"Recurrent nephrotic syndrome following renal transplantation in patients with focal glomerulosclerosis. a one-center study of plasma exchange effects","volume":"52","author":"Dantal","year":"1991","journal-title":"Transplantation"},{"key":"B71","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1056\/NEJM199401063300102","article-title":"Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome","volume":"330","author":"Dantal","year":"1994","journal-title":"N Engl J Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1202500","article-title":"Resolution of recurrent focal segmental glomerulosclerosis after retransplantation","volume":"366","author":"Gallon","year":"2012","journal-title":"N Engl J Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03800609","article-title":"Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis","volume":"5","author":"McCarthy","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00223.x","article-title":"Blockade of CD40-CD40 ligand protects against renal injury in chronic proteinuric renal disease","volume":"64","author":"Kairaitis","year":"2003","journal-title":"Kidney Int"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e0188045","DOI":"10.1371\/journal.pone.0188045","article-title":"Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS","volume":"12","author":"Doublier","year":"2017","journal-title":"PloS One"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2011.03.010","article-title":"CD40 ligand: a neo-inflammatory molecule in vascular diseases","volume":"217","author":"Hassan","year":"2012","journal-title":"Immunobiology"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.22.012703.104533","article-title":"CD40\/CD154 interactions at the interface of tolerance and immunity","volume":"22","author":"Quezada","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015091002","article-title":"B7-1 blockade does not improve post-transplant nephrotic syndrome caused by recurrent FSGS","volume":"27","author":"Delville","year":"2016","journal-title":"J Am Soc Nephrol."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2009.130","article-title":"An overview of small-molecule inhibitors of VEGFR signaling","volume":"6","author":"Ivy","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.344","article-title":"Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy","volume":"85","author":"Izzedine","year":"2014","journal-title":"Kidney Int"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2009.05.019","article-title":"Sorafenib inhibits nuclear factor kappa b, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice","volume":"162","author":"Echeverria","year":"2009","journal-title":"Neuroscience"},{"key":"B82","doi-asserted-by":"publisher","first-page":"ra39","DOI":"10.1126\/scisignal.2000678","article-title":"C-mip impairs podocyte proximal signaling and induces heavy proteinuria","volume":"3","author":"Zhang","year":"2010","journal-title":"Sci Signal"},{"key":"B83","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.molmed.2007.06.006","article-title":"Nephrin\u2013a unique structural and signaling protein of the kidney filter","volume":"13","author":"Patrakka","year":"2007","journal-title":"Trends Mol Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.426","article-title":"Upregulation of c-mip is closely related to podocyte dysfunction in membranous nephropathy","volume":"83","author":"Sendeyo","year":"2013","journal-title":"Kidney Int"},{"key":"B85","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nm1696","article-title":"Modification of kidney barrier function by the urokinase receptor","volume":"14","author":"Wei","year":"2008","journal-title":"Nat Med"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012030302","article-title":"Circulating suPAR in two cohorts of primary FSGS","volume":"23","author":"Wei","year":"2012","journal-title":"J Am Soc Nephrol."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506362","article-title":"Soluble urokinase receptor and chronic kidney disease","volume":"373","author":"Hayek","year":"2015","journal-title":"N Engl J Med"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20110102","article-title":"Angiopoietin-like 4: a decade of research","volume":"32","author":"Zhu","year":"2012","journal-title":"Biosci Rep"},{"key":"B89","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.trsl.2014.06.004","article-title":"The proteinuria-hypertriglyceridemia connection as a basis for novel therapeutics for nephrotic syndrome","volume":"165","author":"Clement","year":"2015","journal-title":"Transl Res"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2261","article-title":"Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome","volume":"17","author":"Clement","year":"2011","journal-title":"Nat Med"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2011.07.024","article-title":"New insights into human minimal change disease: lessons from animal models","volume":"59","author":"Chugh","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00438.x","article-title":"Protease activity of plasma hemopexin","volume":"68","author":"Bakker","year":"2005","journal-title":"Kidney Int"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1995.1173","article-title":"The type II hemopexin interleukin-6 response element predominates the transcriptional regulation of the hemopexin acute phase responsiveness","volume":"207","author":"Immenschuh","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/41.12.1819","article-title":"Lipid peroxidation and antioxidants as biomarkers of tissue damage","volume":"41","author":"Gutteridge","year":"1995","journal-title":"Clin Chem"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007080940","article-title":"Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes","volume":"19","author":"Lennon","year":"2008","journal-title":"J Am Soc Nephrol."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-005-1936-3","article-title":"Altered activity of plasma hemopexin in patients with minimal change disease in relapse","volume":"20","author":"Bakker","year":"2005","journal-title":"Pediatr Nephrol."},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1982.229","article-title":"Glomerular charge alterations in human minimal change nephropathy","volume":"22","author":"Bridges","year":"1982","journal-title":"Kidney Int"},{"key":"B98","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/ki.1987.173","article-title":"Renal selectivity properties towards endogenous albumin in minimal change nephropathy","volume":"32","author":"Ghiggeri","year":"1987","journal-title":"Kidney Int"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1987.243","article-title":"Characterization of cationic albumin in minimal change nephropathy","volume":"32","author":"Ghiggeri","year":"1987","journal-title":"Kidney Int"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304572","article-title":"Abatacept in B7-1-positive proteinuric kidney disease","volume":"369","author":"Yu","year":"2013","journal-title":"N Engl J Med"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-022-05549-7","article-title":"Benefit of B7-1 staining and abatacept for treatment-resistant post-transplant focal segmental glomerulosclerosis in a predominantly pediatric cohort: time for a reappraisal","volume":"38","author":"Burke","year":"2023","journal-title":"Pediatr Nephrol."},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007080836","article-title":"Urinary CD80 excretion increases in idiopathic minimal-change disease","volume":"20","author":"Garin","year":"2009","journal-title":"J Am Soc Nephrol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/ki.2010.143","article-title":"Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis","volume":"78","author":"Garin","year":"2010","journal-title":"Kidney Int"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013050518","article-title":"Role of podocyte B7-1 in diabetic nephropathy","volume":"25","author":"Fiorina","year":"2014","journal-title":"J Am Soc Nephrol."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-017-3613-8","article-title":"Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome","volume":"32","author":"Mishra","year":"2017","journal-title":"Pediatr Nephrol."},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1172\/JCI20402","article-title":"Induction of B7-1 in podocytes is associated with nephrotic syndrome","volume":"113","author":"Reiser","year":"2004","journal-title":"J Clin Invest."},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2005.02862.x","article-title":"Circulating anti-actin and anti-ATP synthase antibodies identify a sub-set of patients with idiopathic nephrotic syndrome","volume":"141","author":"Musante","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.21037\/atm-21-3988","article-title":"The important roles and molecular mechanisms of annexin A(2) autoantibody in children with nephrotic syndrome","volume":"9","author":"Ye","year":"2021","journal-title":"Ann Transl Med"},{"key":"B109","doi-asserted-by":"publisher","first-page":"256ra136","DOI":"10.1126\/scitranslmed.3008538","article-title":"A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation","volume":"6","author":"Delville","year":"2014","journal-title":"Sci Transl Med"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.04.006","article-title":"Atypical IgM on T cells predict relapse and steroid dependence in idiopathic nephrotic syndrome","volume":"96","author":"Colucci","year":"2019","journal-title":"Kidney Int"},{"key":"B111","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1681\/ASN.2006090965","article-title":"Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin","volume":"18","author":"Musante","year":"2007","journal-title":"J Am Soc Nephrol."},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006050486","article-title":"Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome","volume":"17","author":"Candiano","year":"2006","journal-title":"J Am Soc Nephrol."},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018090951","article-title":"Podocyte-specific sialylation-deficient mice serve as a model for human FSGS","volume":"30","author":"Niculovic","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2014.00127","article-title":"Podocyte pathology and nephropathy - sphingolipids in glomerular diseases","volume":"5","author":"Merscher","year":"2014","journal-title":"Front Endocrinol (Lausanne)."},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191699","article-title":"Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosis","volume":"217","author":"Angeletti","year":"2020","journal-title":"J Exp Med"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.10.018","article-title":"Refractory minimal change disease and focal segmental glomerular sclerosis treated with anakinra","volume":"7","author":"Angeletti","year":"2022","journal-title":"Kidney Int Rep"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1991.232","article-title":"A glomerular permeability factor produced by human T cell hybridomas","volume":"40","author":"Koyama","year":"1991","journal-title":"Kidney Int"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)91880-7","article-title":"Pathogenesis of lipoid nephrosis: a disorder of T-cell function","volume":"2","author":"Shalhoub","year":"1974","journal-title":"Lancet"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1159\/000183647","article-title":"Histopathological and immunological studies in spontaneous remission of nephrotic syndrome after intercurrent measles infection","volume":"42","author":"Lin","year":"1986","journal-title":"Nephron"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1159\/000515062","article-title":"A case of nephrotic syndrome that resolved with influenza b infection","volume":"11","author":"Tamura","year":"2021","journal-title":"Case Rep Nephrol Dial."},{"key":"B121","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00467-017-3588-5","article-title":"Does zika virus infection induce prolonged remissions in children with idiopathic nephrotic syndrome","volume":"32","author":"Peralta-Aros","year":"2017","journal-title":"Pediatr Nephrol."},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V103529","article-title":"Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse","volume":"10","author":"Yap","year":"1999","journal-title":"J Am Soc Nephrol."},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.32769","article-title":"T-Lymphocyte populations and cytokines in childhood nephrotic syndrome","volume":"39","author":"Lama","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"B124","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1681\/ASN.2007111244","article-title":"Induction of T regulatory cells attenuates idiopathic nephrotic syndrome","volume":"20","author":"Le Berre","year":"2009","journal-title":"J Am Soc Nephrol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12948-022-00171-2","article-title":"Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life","volume":"20","author":"Nettis","year":"2022","journal-title":"Clin Mol Allergy"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.5534","article-title":"Efficacy and safety of lebrikizumab in combination with topical corticosteroids in adolescents and adults with moderate-to-Severe atopic dermatitis: a randomized clinical trial (ADhere)","volume":"159","author":"Simpson","year":"2023","journal-title":"JAMA Dermatol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2011.02.018","article-title":"Th17\/Treg imbalance in adult patients with minimal change nephrotic syndrome","volume":"139","author":"Liu","year":"2011","journal-title":"Clin Immunol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2011030304","article-title":"Basic and translational concepts of immune-mediated glomerular diseases","volume":"23","author":"Couser","year":"2012","journal-title":"J Am Soc Nephrol."},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-009-1119-8","article-title":"Minimal change nephrotic syndrome associated with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome","volume":"24","author":"Hashimura","year":"2009","journal-title":"Pediatr Nephrol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1365-2249.2011.04441.x","article-title":"Regulation of innate immunity by the nucleotide pathway in children with idiopathic nephrotic syndrome","volume":"166","author":"Bertelli","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2011111130","article-title":"IL-2\/IL-2Ab complexes induce regulatory T cell expansion and protect against proteinuric CKD","volume":"23","author":"Polhill","year":"2012","journal-title":"J Am Soc Nephrol."},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111285","article-title":"LPS nephropathy in mice is ameliorated by IL-2 independently of regulatory T cells activity","volume":"9","author":"Bertelli","year":"2014","journal-title":"PloS One"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.726428","article-title":"CyTOF-enabled analysis identifies class-switched b cells as the main lymphocyte subset associated with disease relapse in children with idiopathic nephrotic syndrome","volume":"12","author":"Fribourg","year":"2021","journal-title":"Front Immunol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197804132981507","article-title":"Molecular basis of proteinuria of glomerular origin","volume":"298","author":"Brenner","year":"1978","journal-title":"N Engl J Med"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1978.41","article-title":"Glomerular filtration of proteins: clearance of anionic, neutral, and cationic horseradish peroxidase in the rat","volume":"13","author":"Rennke","year":"1978","journal-title":"Kidney Int"},{"key":"B136","article-title":"Glomerular sialic acid and proteinuria in human renal disease","volume":"28","author":"Blau","year":"1973","journal-title":"Lab Invest."},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2014.87","article-title":"Lipid biology of the podocyte\u2013new perspectives offer new opportunities","volume":"10","author":"Fornoni","year":"2014","journal-title":"Nat Rev Nephrol."},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1996.271.4.F900","article-title":"Megalin\/gp330 mediates uptake of albumin in renal proximal tubule","volume":"271","author":"Cui","year":"1996","journal-title":"Am J Physiol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010050492","article-title":"Cubilin is essential for albumin reabsorption in the renal proximal tubule","volume":"21","author":"Amsellem","year":"2010","journal-title":"J Am Soc Nephrol."},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa039","article-title":"Immunoglobulin g\/albumin staining in tubular protein reabsorption droplets in minimal change disease and focal segmental glomerulosclerosis","volume":"36","author":"Bu","year":"2021","journal-title":"Nephrol Dial Transplant."},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402025","article-title":"Sialylation of n-linked glycans influences the immunomodulatory effects of IgM on T cells","volume":"194","author":"Colucci","year":"2015","journal-title":"J Immunol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01347","article-title":"Pro-inflammatory state in monoclonal gammopathy of undetermined significance and in multiple myeloma is characterized by low sialylation of pathogen-specific and other monoclonal immunoglobulins","volume":"8","author":"Bosseboeuf","year":"2017","journal-title":"Front Immunol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1235681","DOI":"10.1126\/science.1235681","article-title":"Emerging principles for the therapeutic exploitation of glycosylation","volume":"343","author":"Dalziel","year":"2014","journal-title":"Science"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91781-3","article-title":"Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity","volume":"1","author":"Parekh","year":"1988","journal-title":"Lancet"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/0896-8411(91)90053-f","article-title":"Abnormalities in the glycosylation of IgG in spouses of patients with rheumatoid arthritis","volume":"4","author":"Sumar","year":"1991","journal-title":"A Family study. J Autoimmun"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2009.06.006","article-title":"The oxido-redox potential of albumin methodological approach and relevance to human diseases","volume":"73","author":"Candiano","year":"2009","journal-title":"J Proteomics."},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2013.04.017","article-title":"Oxidized albumin. the long way of a protein of uncertain function","volume":"1830","author":"Bruschi","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B148","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/ki.1991.176","article-title":"Puromycin aminonucleoside metabolism by glomeruli and glomerular epithelial cells","volume":"40","author":"Ghiggeri","year":"1991","journal-title":"vitro. Kidney Int"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00170","article-title":"Molecular and cellular mechanisms for proteinuria in minimal change disease","volume":"5","author":"Bertelli","year":"2018","journal-title":"Front Med (Lausanne)."},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V121143","article-title":"Apolipoproteins prevent glomerular albumin permeability induced in vitro by serum from patients with focal segmental glomerulosclerosis","volume":"12","author":"Candiano","year":"2001","journal-title":"J Am Soc Nephrol."},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138343","article-title":"A pilot study of IL2 in drug-resistant idiopathic nephrotic syndrome","volume":"10","author":"Bonanni","year":"2015","journal-title":"PloS One"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09421010","article-title":"Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial","volume":"6","author":"Ravani","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2018.1323","article-title":"Efficacy of rituximab vs tacrolimus in pediatric corticosteroid-dependent nephrotic syndrome: a randomized clinical trial","volume":"172","author":"Basu","year":"2018","journal-title":"JAMA Pediatr"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1308488","article-title":"Ofatumumab for rituximab-resistant nephrotic syndrome","volume":"370","author":"Basu","year":"2014","journal-title":"N Engl J Med"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015050523","article-title":"B cell reconstitution after rituximab treatment in idiopathic nephrotic syndrome","volume":"27","author":"Colucci","year":"2016","journal-title":"J Am Soc Nephrol."},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-018-0101-4","article-title":"Only follow-up of memory b cells helps monitor rituximab administration to patients with neuromyelitis optica spectrum disorders","volume":"7","author":"Lebrun","year":"2018","journal-title":"Neurol Ther"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1002\/art.21617","article-title":"Reconstitution of peripheral blood b cells after depletion with rituximab in patients with rheumatoid arthritis","volume":"54","author":"Leandro","year":"2006","journal-title":"Arthritis Rheumatol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2017.12.014","article-title":"Autoantibodies against podocytic UCHL1 are associated with idiopathic nephrotic syndrome relapses and induce proteinuria in mice","volume":"89","author":"Jamin","year":"2018","journal-title":"J Autoimmun"},{"key":"B159","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"Kidney disease: improving global outcomes glomerular diseases work g. KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-020-04519-1","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome","volume":"35","author":"Trautmann","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"CD002290","DOI":"10.1002\/14651858.CD002290.pub5","article-title":"Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children","volume":"4","author":"Larkins","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8060860","article-title":"Levamisole in children with idiopathic nephrotic syndrome: clinical efficacy and pathophysiological aspects","volume":"8","author":"Muhlig","year":"2019","journal-title":"J Clin Med"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2021111472","article-title":"Long-term efficacy and safety of repeated rituximab to maintain remission in idiopathic childhood nephrotic syndrome: an international study","volume":"33","author":"Chan","year":"2022","journal-title":"J Am Soc Nephrol."},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2021040561","article-title":"Human or chimeric monoclonal anti-CD20 antibodies for children with nephrotic syndrome: a superiority randomized trial","volume":"32","author":"Ravani","year":"2021","journal-title":"J Am Soc Nephrol."},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.08.006","article-title":"Circulating anti-rituximab antibodies do not affect response to rituximab in steroid-dependent nephrotic syndrome","volume":"7","author":"Angeletti","year":"2022","journal-title":"Kidney Int Rep"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2030183","article-title":"Sotagliflozin in patients with diabetes and recent worsening heart failure","volume":"384","author":"Bhatt","year":"2021","journal-title":"N Engl J Med"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220920","article-title":"B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial","volume":"81","author":"Furie","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B169","doi-asserted-by":"publisher","first-page":"805697","DOI":"10.3389\/fimmu.2022.805697","article-title":"New and old anti-CD20 monoclonal antibodies for nephrotic syndrome","volume":"13","author":"Basu","year":"2022","journal-title":"Where We Are? Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1167741\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T20:00:37Z","timestamp":1689192037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1167741\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,12]]},"references-count":169,"alternative-id":["10.3389\/fimmu.2023.1167741"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1167741","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,12]]},"article-number":"1167741"}}